Personal CFO Solutions LLC Increases Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Personal CFO Solutions LLC grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 287.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,219 shares of the company’s stock after buying an additional 2,389 shares during the quarter. Personal CFO Solutions LLC’s holdings in HCA Healthcare were worth $966,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in HCA. Whipplewood Advisors LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at about $31,000. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $39,000. Activest Wealth Management raised its position in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares during the period. Capital Performance Advisors LLP purchased a new stake in HCA Healthcare in the 3rd quarter worth about $41,000. Finally, Pinnacle Bancorp Inc. raised its position in HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Bank of America reduced their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. KeyCorp dropped their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their target price for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Finally, JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Price Performance

Shares of HCA opened at $330.11 on Friday. The company has a market cap of $81.27 billion, a price-to-earnings ratio of 15.03, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The company has a 50 day moving average of $316.70 and a two-hundred day moving average of $347.49.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the company earned $5.90 earnings per share. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. The ex-dividend date of this dividend is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.